Preclinical Oncology Research Peptide

PNC-27 Research Peptide

A p53-derived peptide studied in published in vitro literature for its binding to membrane-associated HDM-2 on tumor cell lines. Supplied to laboratories for in vitro and preclinical investigation only. Not a drug, not a treatment, and not for human or veterinary use.

99% Purity

Third-Party Tested

HPLC Verified

What the Literature Reports

PNC-27 is one of the more frequently cited p53-derived peptides in published in vitro oncology literature. The summary below describes those published findings, not outcomes in humans.

In Vitro Only

Published work on PNC-27 is limited to cell-culture and animal models. No human clinical efficacy or safety has been established.

Selective Targeting

Published in vitro studies report binding to membrane-associated HDM-2 on tumor cell lines, with lysis not observed in the normal cell lines tested.

Analytical Documentation

Each lot is third-party tested by HPLC with identity and purity documentation available in our lab reports.

How PNC-27 Works

HDM-2 Binding Domain

PNC-27 contains a p53-derived HDM-2 binding domain reported to recognize HDM-2 expressed at the surface of tumor cell lines in culture.

Binds to Membrane

Published in vitro work reports the peptide inserting into the target cell membrane and forming pore-like structures.

Reported Membrane Lysis

That membrane disruption is reported to cause necrosis in the tumor cell lines studied, while the normal cell lines tested — which lack surface HDM-2 — were not lysed.

For laboratory research use only. The statements above summarize published preclinical (cell culture and animal) literature. PNC-27 is not approved by the FDA for any use, has not been shown to be safe or effective in humans, and is not offered to diagnose, treat, cure, or prevent any disease. Not for human or veterinary use.

First Responder Research Stack

A bundled set of research materials frequently ordered together for growth-axis, tissue-repair, and metabolic study work.

Popular

First Responder Stack

Beginner (30mg): CJC-1295 + Ipamorelin 10mg, Wolverine Stack 10mg, GLP-3 RT 10mg. Advanced (60mg): CJC-1295 + Ipamorelin 20mg, Wolverine Stack 20mg, GLP-3 RT 20mg — growth-axis, tissue-repair and metabolic research stack

Bundle

99% Pure

✓ View Certificate of Analysis (COA)

$183.00$203.00

Save $20.00

Veteran & First-Responder Owned

Redline Bio Labs is owned and operated by veterans and first responders. That background shapes how we source, test, and document our catalog — not what the materials may be used for. Everything we list is supplied for laboratory research only. The compounds below are other frequently referenced research peptides in our catalog.